Indian drugmaker Maithili Life Sciences has received a non-compliant report from the Brussels-based Federal Agency for ...

The US Food and Drug Administration (FDA) has issued several warning letters to pharmaceutical manufacturers in India and ...

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...

Neurocrine's pipeline includes 12 clinical programs, with two Phase 3 trials due to report in 2025. See why I rate NBIX stock ...

If implemented, this initiative could be a game-changer. Industry insiders estimate that Bangladesh could save $1 billion in foreign currency annually by reducing its reliance on imported APIs ...

“A 25% tariff on Canada and Mexico threatens to upend the very supply chains that have made U.S. manufacturing more ...

India's Divi's Laboratories reported a better-than-expected quarterly profit on Monday, aided by strong performance of its business that focuses on customised production of chemical compounds used in ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

AdvaMed, the largest medical device association globally, urged the Trump administration to exempt medical products from the ...

The recent imposition of a 10% tariff on Chinese imports is expected to raise the cost of generic drugs in the U.S. and worsen ongoing drug shortages, NBC News reported Feb. 3. Here are five more ...